Concerta Side Effects Linked To Cardiovascular Lawsuits
Concerta Side Effects Injury Lawsuits. The FDA announced on June 29, 2005 that they are adding a new warning concerning psychiatric side effects to the label of Concerta. Concerta is used to treat attention deficit hyperactivity disorder, or ADHD. The FDA approved Concerta manufactured by Johnson and Johnson on August 1, … [Read more...]
Chantix Side Effects Linked to Strokes, Heart Attacks, Cardiovascular & Heart Disease Risk, Lawsuits being Evaluated
New Chantix Side Effects Increased Cardiovascular. A published report states that users of the smoking cessation drug Varenicline, brand name Chantix, has been linked to a small but statistically significant increased risk of cardiovascular events. The study was conducted by CMAJ suggests that 1 in every 28 patients receiving Chantix … [Read more...]
FDA: Research Reveals Adverse Xolair Cardiovascular (Heart) and Cerebrovascular (Brain) Events
Xolair Adverse Events. Federal regulators say that the asthma medication, Xolair (omalizumab), is associated with an increased risk for a number of cardiovascular reactions including, heart attack, mini-stroke, chest pain, and blood clots in the lungs and veins. The U.S. Food and Drug Administration (FDA) also indicated that it had … [Read more...]
Nexavar Raises Blood Pressure
Nexavar Raises Blood Pressure. Nexavar, a drug used to treat kidney and liver cancer, can raise blood pressure substantially, a new study has found. The authors of the Nexavar study wrote in the medical journal “Lancet Oncology” that patents being treated with drug – known generically as sorafenib – should be closely monitored and … [Read more...]
Exposure to Air Pollution May Lead to Cardiovascular Disease
Exposure To Air Pollution Increase Risk Of Cardiovascular Disease. Researchers at the University of Washington report that long-term exposure to air pollution increases the risks of cardiovascular disease and death in postmenopausal women. The findings were published in today’s issue of the New England Journal of Medicine … [Read more...]
New data noted on Vioxx risk
Cardiovascular Risks Related To The Painkiller Vioxx Risk. The risk related to the painkiller Vioxx may begin earlier than what Merck & Co. has said, The Wall Street Journal reports, but the company doesn't agree. The Journal says new company data suggest the cardiovascular risk begins within four months of Vioxx use, and not … [Read more...]
Celebrex: Cardiovascular Risk Similar to Vioxx – IMMP Study
Arthritis Drug Celebrex Increased The Risk Of Heart Attack And Stroke. Patients taking the arthritis drug Celecoxib (Celebrex) have a similar risk of heart attacks and stroke as those taking the withdrawn drug Rofecoxib (Vioxx), according to a new study by the New Zealand Intensive Medicines Monitoring Programme(IMMP). Rofecoxib … [Read more...]
Meridia Must Be Banned
Meridia Sales Must Be Banned. A consumer group Wednesday reiterated its request that the government immediately ban sales of Meridia, a prescription diet drug. Public Citizen said in a letter to Food and Drug Administration Commissioner Mark McClellan that it reviewed the FDA's database and found 49 cases of deaths from … [Read more...]
